Li 2017 [8] |
hepatocellular carcinoma |
upregulation |
promote cell proliferation |
miR-200a/HMGB1/RAGE |
Chen 2018 [27] |
osteosarcoma |
upregulation |
promote cell proliferation, migration and invasion |
|
Ding 2018 [11] |
gastric cancer |
upregulation |
promote cell growth and metastasis |
miR-194-5p/SDAD1 |
Li 2018 [28] |
ovarian cancer |
upregulation |
promote cell proliferation |
|
Liu 2018 [15] |
clear cell renal cell carcinoma |
upregulation |
promote cell proliferation, inhibit cell apoptosis |
KISS/EZH2, PI3K/Akt/mTOR |
Peng 2018 [12] |
gastric cancer |
upregulation |
promote cell proliferation |
HMGB1/RAGE |
Tuo 2018 [16] |
bladder cancer |
downregulation |
inhibit cell growth, cell cycle, migration and invasion, induce cell apoptosis |
EMT |
Wang 2018 [17] |
ovarian cancer |
upregulation |
promoted cell proliferation, invasion, and migration |
MMP2, MMP9 |
Wang 2018 |
gastric cancer |
upregulation |
promote cell proliferation, invasion |
WNT/β-catenin |
Yang 2018 [10] |
osteosarcoma |
upregulation |
promote cell proliferation, invasion |
miR-142/Rac1 |
Yao 2018 [18] |
breast cancer |
upregulation |
promote cell proliferation |
miR-200a/TFAM |
Yao 2018 [6] |
cholangiocarcinoma |
upregulation |
promote cell proliferation, migration, invasion, inhibit cell apoptosis |
|
Zhang 2018 [21] |
non-small cell lung cancer |
upregulation |
promote cell proliferation, tumor growth and cycle progression |
miR-449a/EZH2 |
Zhang 2018 [24] |
brain glioma |
upregulation |
promote cell proliferation and invasion |
miR-142/HMGB1/RAGE |
Zhang 2018 [14] |
gastric cancer |
upregulation |
promote cell migration and invasion |
EMT/Bcl-2/caspase-3 |
Zou 2018 [19] |
breast cancer |
upregulation |
promote cell invasion and migration |
miR-200a/ZEB1 |
Cui 2019 [25] |
pancreatic cancer |
upregulation |
promote migration and invasion |
miR-141-3p/BDH2 |
Jia 2019 [26] |
colorectal cancer |
downregulation |
inhibite cell growth, promote apoptosis |
miR-103/ PTEN |
Liu 2019 [23] |
Lung adenocarcinoma |
upregulation |
promote cell proliferation, migration, invasion, inhibit apoptosis |
PI3K/AKT |
Ma 2019 [9] |
hepatocellular carcinoma |
upregulation |
promote cell proliferation, inhibit apoptosis |
miR-103 |
Zhang 2019 [20] |
cervical cancer |
upregulation |
promote cell proliferation, migration and invasion |
miR-607/cyclin D2 |
Zhu 2019 [22] |
non-small cell lung cancer |
upregulation |
promote cell proliferation. migration and invasion |
miR-21 |
Li 2019 [32] |
colorectal cancer |
upregulation |
promote cell migration and invasion |
TGF-β1 |
Liu 2020 [30] |
gastric cancer |
downregulation |
inhibit cell invasion and migration |
miR-223-5p |
Liu 2020 [31] |
breast cancer |
upregulation |
promote cell proliferation, migration and invasion, inhibite apoptosis |
miRNA-125a-3p/metadherin |
Wang 2020 [33] |
retinoblastoma |
upregulation |
promote cell proliferation, metastasis and invasion |
miRNA-874-3p / TFAP2B |